Braxia Scientific Statistics
Total Valuation
BRAXF has a market cap or net worth of 1.03 million. The enterprise value is 1.39 million.
| Market Cap | 1.03M |
| Enterprise Value | 1.39M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 283.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | -3.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.19 |
| EV / Sales | 0.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.70 |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.24 |
| Interest Coverage | -67.47 |
Financial Efficiency
Return on equity (ROE) is -254.58% and return on invested capital (ROIC) is -59.00%.
| Return on Equity (ROE) | -254.58% |
| Return on Assets (ROA) | -42.36% |
| Return on Invested Capital (ROIC) | -59.00% |
| Return on Capital Employed (ROCE) | -2,940.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -110,464 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.43% in the last 52 weeks. The beta is 1.23, so BRAXF's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -63.43% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 35.42 |
| Average Volume (20 Days) | 7,310 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRAXF had revenue of 1.67 million and -7.30 million in losses. Loss per share was -0.03.
| Revenue | 1.67M |
| Gross Profit | 245,419 |
| Operating Income | -3.01M |
| Pretax Income | -7.41M |
| Net Income | -7.30M |
| EBITDA | -2.81M |
| EBIT | -3.01M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 97,184 in cash and 482,069 in debt, giving a net cash position of -384,885.
| Cash & Cash Equivalents | 97,184 |
| Total Debt | 482,069 |
| Net Cash | -384,885 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -277,022 |
| Book Value Per Share | -0.00 |
| Working Capital | -1.37M |
Cash Flow
In the last 12 months, operating cash flow was -1.96 million and capital expenditures -47,318, giving a free cash flow of -2.00 million.
| Operating Cash Flow | -1.96M |
| Capital Expenditures | -47,318 |
| Free Cash Flow | -2.00M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 14.67% |
| Operating Margin | -179.96% |
| Pretax Margin | -442.97% |
| Profit Margin | n/a |
| EBITDA Margin | -168.06% |
| EBIT Margin | -179.96% |
| FCF Margin | n/a |
Dividends & Yields
BRAXF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.88% |
| Shareholder Yield | -20.88% |
| Earnings Yield | -711.12% |
| FCF Yield | -195.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BRAXF has an Altman Z-Score of -74.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -74.79 |
| Piotroski F-Score | 3 |